Παρασκευή 24 Φεβρουαρίου 2017

CHMP grants positive opinion to dabrafenib and trametinib for BRAF positive NSCLC

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of dabrafenib in combination with trametinib to treat patients with advanced or metastatic non-small...

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2lB6jMt
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Δημοφιλείς αναρτήσεις